Published in Immunotherapy Weekly, June 18th, 2008
"In addition, TNF-a concentration in patients with and without fever were found to be significant (p=0.0001,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.